神经节苷脂类抑制BT325细胞系的生长

应用自提的神经节苷脂GM3, 牛脑神经节苷脂(bovine brain gangliosides, BBG)加入低血清培养的人多形成胶质细胞瘤BT325细胞中观察其对该细胞系的影响; 以及GM3、BBG对表皮生长因子(EGF)刺激该细胞系生长的拮抗作用. 结果表明GM3、BBG均能抑制BT325细胞生长,GM3的抑制作用远高于BBG, 其抑制率为60.28% (P＜0.01), BBG为19.33％,在含不同浓度的EGF培养液中分别加入GM3、BBG均可拮抗EGF对BT325生长的刺激作用, GM3的拮抗作用远高于BBG.     

外源性神经节苷脂GM3影响人肝癌细胞生长的可能机制的初步研究

通过苔酚蓝染色细胞发现,外源性ＧＭ３能明显抑制人肝癌细胞株ＳＭＭＣ－７７２１细胞生长,在ＧＭ３处理３ｄ时,出现明显差异,通过ＮｏｒｔｈｅｒｎＢｌｏｔ分析发现,外源性ＧＭ３可明显影响人肝癌细胞株ＳＭＭＣ－７７２１细胞中ｃ－ｆｏｓ、ｃ－ｊｕｎ、ｃ－ｍｙｃ和Ｎ－ｒａｓ四种癌基因的ｍＲＮＡ表达,未经ＧＭ３处理的细胞中没有检测到ｃ－ｆｏｓｍＲＮＡ,但ｃ－ｊｕｎ微量表达,并有ｃ－ｍｙｃ和Ｎ－ｒａｓｍＲＮＡ的高     

外源性神经节苷脂GM_3影响人肝癌细胞生长的可能机制的初步研究

通过苔酚蓝染色细胞发现,外源性GM3（10μg/ml）能明显抑制人肝癌细胞株SMMC-7721细胞生长,在GM3处理3d时,出现明显差异．通过NorthernBlot分析发现,外源性GM3可明显影响人肝癌细胞株SMMC-7721细胞中c-fos、c-jun、c-myc和N-ras这四种癌基因的mRAN表达．未经GM3处理的细胞中没有检测到c-fosmRNA,但c-jun微量表达,并有c-myc和N-rasmRNA的高水平表达而GM3可在短时间内快速大量地诱导c-fos、c-junmRNA的生成．GM3处理的细胞,c-myc和N-rasmRNA的表达均明显减少．GM3处理45min时,c-myc基因表达只为对照组的39．55％;GM3处理24h时,N-ras基因表达为对照组的30.48％．以上结果提示：GM3抑制SMMC-7721细胞生长很可能是通过改变癌基因表达来实现的．     

神经节苷脂GM_3对人白血病J6-2细胞PKC转位及DAG含量的影响

应用SDS PAGE及Western印迹技术检测神经节苷脂GM3 处理前后人白血病J6 2细胞不同类型PKC在细胞内的转位情况 ,同时利用高效薄板层析技术观察了细胞内DAG含量的变化 ,从而探讨GM3 抑制PKC活性的机制 .实验发现 ,GM3 处理后胞液PKCα明显增加 ,而颗粒结合PKCα则相对减少 ;GM3 对其它亚型PKC在细胞内分布无显著影响 .同时还发现 ,GM3 处理后细胞内DAG含量降低 (P <0 0 5 ) .结果表明 ,GM3 抑制PKCα由胞浆向质膜转位 ,对其它亚型PKC在细胞内转位无影响 .提示GM3 抑制的PKC亚型可能是PKCα .同时GM3 降低细胞内DAG含量 ,这可能与GM3抑制PKCα活性机制有关     

神经节苷脂GM_3对J6－2细胞蛋白质磷酸化的影响

通过研究神经节苷脂ＧＭ＿３对国人单核样白血病细胞系Ｊ６－２细胞蛋白质磷酸化的影响,在［γ－￣３２Ｐ］ＡＴＰ,ＧＭ＿３,ＡＴＰ,Ｍｇ￣（２＋）与Ｊ６－２细胞液及颗粒两部分共同反应,１Ｏｍｉｎ（３０℃）体系中,观察到ＧＭ＿３对两部分蛋白质磷酸化的调节作用。ＧＭ＿３（１００μｍｏｌ／Ｌ）促进颗粒部分分子量为１８００００,８７０００,７８０００,６７０００,４３０００及３１０００的蛋白质磷酸化,促进胞液部分分子量为８７０００及５６０００的蛋白质磷酸化,而且能抑制７００００及４３０００蛋白质磷酸化。由于ＧＭ＿３已被前人证实能对Ｊ６－２细胞起分化作用,其作用时间长达４－６ｄ,很可能ＧＭ＿３对蛋白质磷酸化作用的调节是ＧＭ＿３促分化作用的早期信号。     

神经节苷脂对脂多糖损伤大鼠嗜铬细胞瘤细胞的保护作用

目的：研究内源性神经节苷脂对大鼠嗜铬细胞瘤细胞株（PC12）脂多糖（LPS）损伤后的作用及机制。方法：培养PC12细胞,建立LPS损伤模型,采用MTT法检测不同浓度LPS对PC12细胞存活率的改变、葡萄糖神经酰胺合成酶抑制剂D（D-PDMP）耗竭内源性神经节苷脂时LPS对PC12细胞存活率的改变以及添加外源性神经节苷脂GM1后对PC12细胞存活率的保护作用;倒置显微镜和荧光显微镜观察细胞状态;RT-PCR检测NF-κB的相对表达含量。结果：LPS能导致PC12细胞形态学的改变及存活率下降,且随着LPS浓度的增加细胞存活率逐渐降低;神经节苷脂GM1能明显改善LPS所致的细胞形态学以及存活率的改变;工具药D-PDMP耗竭内源性神经节苷脂后,LPS对PC12细胞的损伤更严重,添加外源性神经节苷脂GM1,细胞形态学及存活率得到明显改善,细胞存活率上升;LPS损伤时细胞内NF-κB含量增加;D-PDMP预先耗竭内源性神经节苷脂时NF-κB含量增加更多;添加外源性神经节苷脂GM1后NF-κB含量降低。结论：内源性神经节苷脂对PC12细胞LPS损伤具有保护作用,可能是通过NF-κB信号通路来发挥作用的。     

神经节苷脂GM3对重建Ca 2+ -ATP酶构象的调节

应用稳态荧光和纳秒时间分辨瞬态荧光技术,以不同性质猝灭剂探测了神经节苷脂GM3诱发的Ca ²⁺-ATP酶构象的变化.结果显示,GM3可使重建的Ca ²⁺-ATP酶蛋白内源荧光寿命明显延长;并且能不同程度地减弱离子性猝灭剂碘化钾(I^-)和脂溶性猝灭剂竹红菌乙素(HB)对Ca ²⁺-ATP酶色氨酸(Trp)内源荧光的猝灭程度.进一步用时间分辨荧光猝灭动力学分析,当体系中有GM3存在时,HB对该蛋白不同荧光寿命组分的Trp内源荧光猝灭的幅度减小.猝灭常数(K_sv)明显降低.说明GM3依靠其亲水糖链和疏水的神经酰胺链作用,不仅可以改变重建Ca ²⁺-ATP酶蛋白嵌于膜脂疏水区内部的构象,使位于膜脂疏水区不同部位的Trp残基更加趋向排列于亲水-疏水域界面;而且还使Ca ²⁺-ATP酶亲水-疏水结构域之间更趋接近,致使整个酶蛋白分子呈现较“紧凑”的构象,表达较高的酶活力.     

Mutant NG108-15 cells (NG-CR72) deficient in GM1 synthase respond aberrantly to axonogenic stimuli and are vulnerable to calcium-induced apoptosis: they are rescued with LIGA-20

The neuroblastoma x glioma NG108-15 hybrid cell line, a widely used model for the study of neuronal differentiation, contains a variety of gangliosides including GM1 and its sialosylated derivative, GD1a. To investigate the role of these a-series gangliotetraose gangliosides in neuritogenesis, we have obtained a mutated subclone of NG108-15 that is deficient in that family of gangliosides. NG108-15 cells were grown in the presence of cholera toxin, which killed the large majority of cells, and from the cholera-resistant survivors we isolated a clone, NG-CR72, that lacks GM1 and GD1a in the plasma and nuclear membranes. GM2 concentration was significantly higher in the plasma membrane. Enzyme assay indicated deficiency of UDP-Gal:GM2 galactosyltransferase (GM1 synthase), which was confirmed by incorporation studies with [3H]sphingosine. These cells resembled wild-type NG108-15 in extending dendritic processes in response to dendritogenic agents (retinoic acid, dibutyryl cAMP) but responded aberrantly to axonogenic stimuli (KCl, ionomycin) by extending unstable neurites that showed the cytoskeletal staining characteristic of dendrites. Moreover, mutant cells treated with the Ca2+ elevating axonogenic agents underwent apoptosis over time, attributed to dysfunction of Ca2+ regulatory mechanisms normally mediated by GM1. Such agents caused dramatic and sustained elevation of intracellular Ca2+ in mutant cells, in contrast to modest and temporary elevation in wild-type cells. Exogenous GM1, inserted into the plasma membrane, had no discernable protective effect on NG-CR72 cells whereas LIGA-20, a membrane-permeant derivative of GM1 that entered both plasma and nuclear membranes, blocked apoptosis, permitted extension of stable neurites, and attenuated the abnormal elevation of intracellular Ca2+.     

Activation of ganglioside GM3 biosynthesis in human monocyte/macrophages during culturing <Emphasis Type="Italic">in vitro</Emphasis>

We found that GM3 levels in human peripheral blood monocytes and cultured monocyte-derived macrophages were 0.37 and 2.7 μg per million cells, respectively. GM3 synthase of monocytes and to a greater extent of monocyte-derived macrophages was shown to be able to sialylate endogenous substrate, lactosylceramide (LacCer), to form GM3. With exogenously added LacCer, GM3 synthase activity was 57.1 and 563 pmol/h per mg protein in monocytes and monocyte-derived macrophages, respectively. The revealed changes in ganglioside GM3 biosynthesis are specific as the activity of some other sialyltransferases under these conditions was not altered. Human anti-GM3 synthase antibody detected in monocytes a main protein with molecular weight of 60 kD and minor proteins with molecular masses of 52 and 64 kD. In monocyte-derived macrophages the amounts of 60 kD protein and especially 64 kD protein sharply rose. Thus, the increase in ganglioside GM3 levels, GM3 synthase activity, and the enzyme amounts during culturing of monocyte/macrophages may be one of the mechanisms of in vivo increased ganglioside GM3 levels in arterial atherosclerotic lesions. Published in Russian in Biokhimiya, 2007, Vol. 72, No. 7, pp. 948–954.     

Potentiation of a sodium-calcium exchanger in the nuclear envelope by nuclear GM1 ganglioside

Calcium is recognized as an important intracellular messenger with a pivotal role in the regulation of many cytosolic and nuclear processes. Gangliosides of various types, especially GM1, are known to have a role in some aspects of Ca2+ regulation, operating through a variety of mechanisms that are gradually coming to light. The present study provides evidence for a sodium-calcium exchanger in the nuclear envelope of NG108-15 neuroblastoma cells that is potently and specifically activated by GM1. Immunoblot analysis revealed an unusually tight association of GM1 with the exchanger in the nuclear envelope but not with that in the plasma membrane. Exchanger and associated GM1 were located in the inner membrane of the nuclear envelope, suggesting this system could function to transfer Ca2+ between nucleoplasm and the envelope lumen. The GM1-enhanced exchange was blocked by cholera toxin B subunit while C2-ceramide, a recently discovered inhibitor of the exchanger, blocked all transfer. Exchanger activity was significantly elevated in nuclei isolated from cells that were induced to differentiate by KCl + dibutyryl-cAMP, a treatment previously shown to promote up-regulation of nuclear GM1 in conjunction with axonogenesis. Similar enhancement was achieved by addition of exogenous GM1 to nuclei from undifferentiated cells. These results suggest a prominent role for nuclear GM1 in regulation of nuclear Ca2+ homeostasis.     

Ganglioside GM3 and its biological functions

Metabolism, topology, and possible mechanisms for regulation of the ganglioside GM3 content in the cell are reviewed. Under consideration are biological functions of GM3, such as involvement in cell differentiation, proliferation, oncogenesis, and apoptosis.     

Melatonin inhibits the proliferation of retinal pigment epithelial (RPE) cells in vitro

Summary The possible antiproliferative effect of melatonin on retinal pigment epithelial (RPE) cells in vitro was investigated. Bovine RPE cells cultured in Ham’s F12 medium supplemented with 10% fetal bovine serum had a nuclear density of 73.6 ± 6.1 nuclei/mm² at 72 h after seeding. The nuclear density at this time-point was doubled if either 50 or 100 ng/ml human epidermal growth factors (hEGF) was added to the culture medium. When these hEGF-stimulated cells were treated with melatonin from 10 to 500 pg/ml, the proliferation was suppressed with a dose-response relationship. At 250 and 500 pg/ml melatonin, the nuclear densities of the melatonin-treated cells were similar to those of the control cells. Using mitotically active SV-40 transformed human fetal RPE cells cultured in a serum-free medium, melatonin was also shown to be antiproliferative. In the presence of 500 pg/ml melatonin, the proliferation of these cells was inhibited to 77% as compared to the control. These results were further supported by the reduced [H³]thymidine uptake in the melatonin-treated cells. We propose that melatonin, at physiologic concentrations, has an antiproliferative effect, and that cultured RPE cells stimulated to proliferate by either hEGF treatment or SV-40 transfection are responsive to melatonin. Melatonin may either inhibit mitosis in actively dividing cells or modulate hEGF action.     

Establishment and Partial Characterization of a Continuous Human Malignant Glioma Cell Line: NG97

1. A human glioma cell line, NG97, was established from tissue obtained from a patient diagnosed with a grade III astrocytoma.2. The NG97 cell line has been subcultured for more than 100 passages in standard culture media without feeder layer or collagen coatings.3. NG97 cells grow in vitro as two subpopulations with distinct morphological appearance: stellate cells with pleomorphic nuclei, and small round cells with few processes. The cells have a doubling time of about 72 h and a plating efficiency of 1%. The injection of NG97 cells into congenitally athymic mice induced the formation of solid tumor masses that could be retransplanted every 4 weeks. The cells obtained from tumor mass when cultivated in vitro had a morphology comparable to those of the initial culture.4. This cell line may prove useful for cellular and molecular studies as well as in studies of gliomas treatment.     

Interleukin-3-associated ganglioside GD1a is induced independently of normal interleukin-3 receptor in murine myelogenous leukaemia NFS60 cells transfected with the interleukin-3 gene

The mechanism of interleukin-3 (IL-3) independent cell growth and of IL-3-associated ganglioside expression was analysed using the IL-3 dependent murine myelogenous leukaemia cell line NFS60-17 andIL-3 gene-transfected sublines. The transfected cell lines showed autonomous cell growth, tumorigenicity, and IL-3 associated ganglioside GD1a expression in spite of their IL-3 production. While the parental NFS60-17 cells did not express significant amounts of GD1a, exogenous recombinant IL-3 (rIL-3) was demonstrated to induce IL-3-associated ganglioside GD1a expression in NFS60-17 cells. Furthermore, the growth potential of the transfected cells was not blocked by anti-IL-3 antibody and expression of GD1a was not affected by anti-IL-3 antibody. These findings suggest that IL-3 expressed intracellularly by gene transfection might act independently of the normal IL-3 receptor on autonomous cell growth and on IL-3-associated GD1a expression in murine myelogenous leukaemia NFS60 cells. Abbreviations: IL-3, interleukin-3; rIL-3, recombinant interleukin-3; FCS, fetal calf serum; PWM-SCCM, pokeweed mitogen-stimulated spleen cell conditioned medium; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide; DEAE, diethylaminoethyl; HPTLC, high performance thin layer chromatography. Glycosphingolipids are designated according to the recommendation of the Nomenclature Committee of the IUPAC [29] and gangliosides are designated as described [30].     

Cytotoxicity of carboplatin on human glioblastoma cells is reduced by the concomitant exposure to an extremely low-frequency electromagnetic field (50 Hz, 70 G)

Glioblastoma multiforme (GBM) is a malignant brain cancer that causes high mortality in patients. GBM responds weakly to the common cancer treatments such as chemotherapy and radiotherapy and even surgery. Carboplatin is an alkylating agent widely used to treat cancer. However, resistance to this drug is a common problem in its use in cancer treatment. Concomitant exposure to extremely low-frequency electromagnetic fields (ELF-EMFs) and carboplatin is one unexplored possibility for overcoming this resistance. Indeed, many lines of evidence show that EMF affects cancer cells and drug action. In this study, we evaluated the effect of concomitant administration of carboplatin and EMF (50 Hz, 70 G) and also concomitant administration of carboplatin and static magnetic field (SMF) (70 G) on human glioma cell line (U-87). The results showed that cotreatment reduced the efficiency of carboplatin in U-87 cells, by decreasing caspase-3 in comparison to drug groups. Overall, EMF reduced the apoptotic effect of carboplatin, possibly through a redox regulation mechanism. Therefore, we have to avoid coadministration of magnetic field (MF) and carboplatin in tumor area, because the MF decreased the toxicity of the drug. However, further studies are needed to reveal the action mechanism of this combination therapeutic method.